ODDB.org: Open Drug Database

Helvepharm AG - Tamsulosin retard Zentiva 0.4 mg, Hartkapseln, retardiert

Swissmedic Registration	67254	Sequence	01
Product name	Tamsulosin retard Zentiva 0.4 mg	Description	Hartkapseln, retardiert
ATC-Classification	G04CA02	ATC-Description	Tamsulosin
Introduction of Sequence	19.06.2019

Composition

tamsulosini hydrochloridum 0.4 mg corresp. tamsulosinum 0.367 mg, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.0264 mg, cellulosum microcristallinum, dibutylis sebacas, polysorbatum 80, silica colloidalis hydrica, calcii stearas, Kapselhülle: gelatina, E 132, E 172 (nigrum), E 172 (rubrum), E 172 (flavum), E 171, pro capsula.

Packungsbestandteile

Galenic Form

Capsules

Active Agent	Dose
Tamsulosini Hydrochloridum	0.4 mg correspond Tamsulosinum 0.367 mg

BAG: Active Agent	Dose
Tamsulosine Hydrochloride	0.4 mg

Inactive agents		additional_information
(Flavum)
(Nigrum)
(Rubrum)
Acidi Methacrylici
Calcii Stearas
Cellulosum Microcristallinum
Dibutylis Sebacas
E 132		color.
E 171		color.
E 172		color.
Ethylis Acrylatis Polymerisatum
Gelatina		Kapselhülle
Natrii Laurilsulfas
Polysorbatum 80
Pro Capsula
Silica Colloidalis Hydrica

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	10	4.66	14.30	B	SL	No
002	30	10.11	27.45	B	SL	No
003	100	33.06	52.35	B	SL	No

2026	©ywesee GmbH